Diamine Oxidase (DAO) is the Primary Enzyme for Histamine Intolerance
Diamine oxidase (DAO) is the key enzyme responsible for breaking down dietary histamine in histamine intolerance. This copper-dependent enzyme is primarily produced by differentiated enterocytes in the intestinal mucosa and serves as the main mechanism for metabolizing exogenous histamine from food 1.
Understanding the Mechanism
When DAO activity is insufficient or inhibited, histamine accumulates in the intestinal lumen and enters systemic circulation, leading to the constellation of symptoms characteristic of histamine intolerance (HIT). The guideline evidence explicitly identifies that food intolerance may result from "inhibition of diamine oxidase to metabolize histamine" 1. This is fundamentally different from IgE-mediated food allergy, which involves immune system activation and mast cell degranulation.
Clinical Implications
DAO deficiency is the primary pathophysiologic mechanism underlying histamine intolerance, distinguishing it from true allergic reactions:
- In food allergy: Mast cells release preformed histamine through IgE-mediated degranulation 1
- In histamine intolerance: Dietary histamine cannot be adequately degraded due to insufficient DAO activity, leading to accumulation 2, 3, 4
Recent research confirms that DAO deficiency affects a substantial portion of the population, with genetic polymorphisms in DAO genes being highly prevalent (78.57% carrying at least one risk allele in one study) 5. However, the presence of genetic variants alone does not predict symptom severity, highlighting the multifactorial nature of HIT 5.
Diagnostic Considerations
The diagnosis of histamine intolerance remains challenging due to lack of standardized biomarkers 2, 3. While serum DAO activity has been proposed as a diagnostic marker, its interpretation is complex—mucosal DAO activity may differ from circulating levels, and measurement methods lack standardization 4.
The diagnosis primarily relies on:
- Clinical assessment of characteristic symptoms (gastrointestinal, dermatologic, neurologic, cardiovascular)
- Response to low-histamine diet
- Symptom recurrence upon histamine reintroduction 2
Management Approach
Primary treatment centers on dietary histamine restriction combined with addressing DAO deficiency 2, 3:
Low-histamine diet: Avoid aged cheeses, fermented foods, cured meats, certain fish (especially spoiled fish which can cause scombroid poisoning from bacterial histidine decarboxylase) 6
DAO supplementation: Emerging evidence suggests exogenous DAO supplementation may help degrade intestinal histamine, though efficacy varies based on enzyme source (porcine vs. plant-based) and presence of cofactors 2, 7, 3, 8
Avoid DAO inhibitors: Certain medications and alcohol can further suppress DAO activity 9
Important Caveats
Do not confuse histamine intolerance with IgE-mediated food allergy—they require entirely different management. Patients with true anaphylaxis need epinephrine autoinjectors 10, 11, while those with histamine intolerance benefit from dietary modification and DAO supplementation. Antihistamines (H1 and H2 blockers) may provide symptomatic relief but do not address the underlying DAO deficiency 10, 12, 11.
The therapeutic landscape is evolving, with novel DAO preparations showing promise for both food treatment and oral supplementation 7, 8, though standardized diagnostic criteria and treatment protocols remain needed 5, 2, 3.